28051306|t|H2O2 -Responsive Vesicles Integrated with Transcutaneous Patches for Glucose -Mediated Insulin Delivery
28051306|a|A self-regulated "smart" insulin administration system would be highly desirable for diabetes management. Here, a glucose -responsive insulin delivery device, which integrates H2O2 -responsive polymeric vesicles (PVs) with a transcutaneous microneedle -array patch was prepared to achieve a fast response, excellent biocompatibility, and painless administration. The PVs are self-assembled from block copolymer incorporated with polyethylene glycol (PEG) and phenylboronic ester (PBE)- conjugated polyserine (designated mPEG-b-P(Ser-PBE)) and loaded with glucose oxidase (GOx) and insulin. The polymeric vesicles function as both moieties of the glucose sensing element (GOx) and the insulin release actuator to provide basal insulin release as well as promote insulin release in response to hyperglycemic states. In the current study, insulin release responds quickly to elevated glucose and its kinetics can be modulated by adjusting the concentration of GOx loaded into the microneedles. In vivo testing indicates that a single patch can regulate glucose levels effectively with reduced risk of hypoglycemia.
28051306	0	4	H2O2	T103	UMLS:C0020281
28051306	17	25	Vesicles	T017	UMLS:C1622418
28051306	42	56	Transcutaneous	T058	UMLS:C0443325
28051306	57	64	Patches	T103	UMLS:C1707974
28051306	69	76	Glucose	T103	UMLS:C0017725
28051306	87	94	Insulin	T103	UMLS:C0021641
28051306	106	120	self-regulated	T033	UMLS:C0243095
28051306	129	136	insulin	T103	UMLS:C0021641
28051306	189	208	diabetes management	T058	UMLS:C0948092
28051306	218	225	glucose	T103	UMLS:C0017725
28051306	280	284	H2O2	T103	UMLS:C0020281
28051306	297	315	polymeric vesicles	T074	UMLS:C1720563
28051306	317	320	PVs	T074	UMLS:C1720563
28051306	329	343	transcutaneous	T058	UMLS:C0443325
28051306	344	355	microneedle	T074	UMLS:C0025080
28051306	363	368	patch	T103	UMLS:C1707974
28051306	395	408	fast response	T201	UMLS:C0521982
28051306	451	465	administration	T058	UMLS:C1533734
28051306	471	474	PVs	T074	UMLS:C1720563
28051306	499	514	block copolymer	T103	UMLS:C0596383
28051306	533	552	polyethylene glycol	T103	UMLS:C0032483
28051306	554	557	PEG	T103	UMLS:C0032483
28051306	563	582	phenylboronic ester	T103	UMLS:C0014898
28051306	584	587	PBE	T103	UMLS:C0014898
28051306	590	600	conjugated	T082	UMLS:C0522529
28051306	601	611	polyserine	T103	UMLS:C0163553
28051306	624	641	mPEG-b-P(Ser-PBE)	T103	UMLS:C0005479
28051306	659	674	glucose oxidase	T103	UMLS:C0017735
28051306	676	679	GOx	T103	UMLS:C0017735
28051306	685	692	insulin	T103	UMLS:C0021641
28051306	698	716	polymeric vesicles	T074	UMLS:C1720563
28051306	750	773	glucose sensing element	T103	UMLS:C0017735
28051306	775	778	GOx	T103	UMLS:C0017735
28051306	788	795	insulin	T103	UMLS:C0021641
28051306	824	829	basal	T082	UMLS:C0205112
28051306	830	837	insulin	T103	UMLS:C0021641
28051306	865	872	insulin	T103	UMLS:C0021641
28051306	896	916	hyperglycemic states	T038	UMLS:C0020456
28051306	940	947	insulin	T103	UMLS:C0021641
28051306	976	992	elevated glucose	T033	UMLS:C0495706
28051306	1017	1026	modulated	T082	UMLS:C0443264
28051306	1061	1064	GOx	T103	UMLS:C0017735
28051306	1081	1093	microneedles	T074	UMLS:C0025080
28051306	1095	1102	In vivo	T082	UMLS:C1515655
28051306	1135	1140	patch	T103	UMLS:C1707974
28051306	1154	1168	glucose levels	T033	UMLS:C0428548
28051306	1202	1214	hypoglycemia	T038	UMLS:C0020615